12‐month safety and efficacy of everolimus with reduced exposure cyclosporine in de novo renal transplant recipients
暂无分享,去创建一个
J. Pascual | H. Tedesco-Silva | P. Rigotti | J. Eris | J. Whelchel | J. Magee | Š. Vítko | S. Campbell | T. Haas | R. Esmeraldo | V. Garcia | V. Cambi | B. Bourbigot | G. Alves-Filho | J. Leone | G. Civati | G. Alves‐Filho